Makers Laboratories Ltd

Makers Labs. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Makers Laboratories Ltd

₹ 156 -2.53%
13 Dec - close price
makerslabs.com BSE: 506919
About

Incorporated in 1984, Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. [1]

Key Points

Product Portfolio
The Co’s product portfolio covers a wide range of General Health Therapeutic segments. Its top formulation brands are Duramol (Paracetamol), Artemak-AB (a-ß Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). [1]

Website BSE
  • Market Cap ₹ 91.9 Cr.
  • Current Price ₹ 156
  • High / Low ₹ 190 / 108
  • Stock P/E 14.3
  • Book Value ₹ 111
  • Dividend Yield 0.00 %
  • ROCE -1.53 %
  • ROE -7.33 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has a low return on equity of -1.11% over last 3 years.
  • Earnings include an other income of Rs.10.9 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
33.57 29.47 27.29 25.45 26.50 19.88 29.45 25.01 25.06 26.51 27.81 29.59 29.57
27.66 24.93 25.25 25.44 24.87 20.06 27.66 25.15 24.86 26.31 26.95 27.78 27.38
Operating Profit 5.91 4.54 2.04 0.01 1.63 -0.18 1.79 -0.14 0.20 0.20 0.86 1.81 2.19
OPM % 17.61% 15.41% 7.48% 0.04% 6.15% -0.91% 6.08% -0.56% 0.80% 0.75% 3.09% 6.12% 7.41%
0.61 1.37 0.62 1.01 0.88 0.27 0.12 0.25 0.41 0.37 0.43 -0.51 10.63
Interest 0.50 0.39 0.41 0.39 1.07 0.42 0.25 0.41 0.49 0.53 0.52 0.49 0.43
Depreciation 1.03 1.01 0.99 0.89 1.03 1.19 1.13 1.11 1.13 1.16 1.15 1.28 1.29
Profit before tax 4.99 4.51 1.26 -0.26 0.41 -1.52 0.53 -1.41 -1.01 -1.12 -0.38 -0.47 11.10
Tax % 28.46% 22.84% 26.98% 219.23% 82.93% 17.11% 33.96% 18.44% 10.89% -4.46% 152.63% 48.94% 11.98%
3.57 3.49 0.93 -0.83 0.07 -1.78 0.35 -1.66 -1.13 -1.06 -0.97 -0.70 9.76
EPS in Rs 2.95 3.44 -1.03 -2.75 -1.08 -3.75 -0.47 -3.56 -2.27 -2.61 -2.19 -1.66 14.95
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
69 127 101 104 113
60 108 98 103 108
Operating Profit 8 19 3 1 5
OPM % 12% 15% 3% 1% 4%
1 3 2 2 11
Interest 2 2 2 2 2
Depreciation 5 4 4 5 5
Profit before tax 3 16 -1 -4 9
Tax % 50% 25% 161% 23%
1 12 -2 -5 7
EPS in Rs -0.56 8.44 -8.05 -10.61 8.49
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 15%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 253%
Stock Price CAGR
10 Years: 17%
5 Years: 34%
3 Years: -7%
1 Year: 23%
Return on Equity
10 Years: %
5 Years: %
3 Years: -1%
Last Year: -7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 5 5 6 6 6
Reserves 49 55 63 57 60
21 23 17 22 15
62 62 66 76 73
Total Liabilities 136 144 152 161 154
71 68 85 87 83
CWIP 0 9 0 0 2
Investments 2 0 0 3 0
63 66 67 71 68
Total Assets 136 144 152 161 154

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 18 -9 1
0 -22 1 -7
0 0 6 6
Net Cash Flow 0 -3 -2 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 88 39 72 70
Inventory Days 344 166 281 227
Days Payable 182 38 91 126
Cash Conversion Cycle 250 167 262 170
Working Capital Days 159 104 139 128
ROCE % 15% 1% -2%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
58.37% 58.37% 61.27% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28%
41.63% 41.63% 38.72% 38.73% 38.73% 38.72% 38.73% 38.73% 38.74% 38.73% 38.74% 38.73%
No. of Shareholders 4,0754,6674,7534,8394,6214,4834,4024,2834,1794,1764,0904,008

Documents

Announcements

Annual reports

Right Issue

Credit ratings